Posted by Michael Wonder on 05 Feb 2016
Dr. Reddy’s Laboratories Ltd. receives FDA approval for Zembrace SymTouch (sumatriptan succinate) injection for the acute treatment of migraines in adults
29 January 2016 - Zembrace SymTouch is available as a prefilled, ready-to-use, single-dose disposable autoinjector containing 3 mg of sumatriptan, a selective 5-HT1B/ID receptor agonist.
For more details, go to: http://www.drreddys.com/media/215069/press-release-zembrace-symtouch_29-jan-2016.pdf
